Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
This program, part of Horizon Europe, focuses on enhancing pandemic preparedness by deepening the understanding of viral proteins and their immunogenicity. It aims to accelerate the development of innovative vaccine candidates against emerging and re-emerging viral infections, thereby strengthening global health security and Europe's role in therapeutic research and development.
Who is Funded for Pandemic Preparedness and Response
This section outlines the eligibility criteria for applicants, the geographical scope of the program, and its core objectives. The funding targets scientific and clinical communities globally, with a specific focus on developing crucial knowledge and interventions for pandemic preparedness.
What is Funded in Viral Immunogenicity Research
This section details the specific types of projects and activities eligible for funding, focusing on critical research areas, the developmental stages of supported projects, and information on eligible costs. The program prioritizes research and innovation in vaccine development and related fields for high-threat viruses.
Type and Scope of Funding for Health Innovations
This section outlines the financial parameters of the program, including the type of financial support provided, the maximum funding available per project, and information on project duration. The program primarily offers grants to support crucial research and innovation actions.
Conditions and Requirements for Applicants
This section covers the essential conditions and requirements for applicants and beneficiaries, including detailed rules for application submission, consortium formation, and adherence to various regulations. Adherence to these conditions is crucial for successful participation.
Application and Selection Process
This section outlines the application and selection processes for the funding program, from submission procedures to how applications are evaluated and awards are granted. It provides a clear guide for prospective applicants.
Legal Basis of the Funding Program
This section details the foundational legal and official documents that govern the funding program, ensuring transparency and compliance. It identifies the primary authorization and other key regulations that shape its operation.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
8,000,000 €
Allocated Budget:
50,000,000 EUR
Deadline:
13.04.2023
Open Until:
Ongoing
Award Channel:
Framework Programme Call
Region:
European Union and globally, including United States of America.
Sectors:
Healthcare, Research and Development, Pharmaceutical Industry
Beneficiaries:
Scientific and clinical communities
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Commission
Additional Partners:
European Health Emergency and Response Authority (HERA)
Website: